BioVie (BIVI) Stock Chart & Stock Price History $1.19 +0.08 (+7.21%) Closing price 06/12/2025 04:00 PM EasternExtended Trading$1.15 -0.04 (-3.03%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioVie Stock Price Performance The BioVie (BIVI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 144.76%, with a year-to-date return of -40.50%. In the past month, the stock has increased 11.21%, reflecting recent market activity. As of the latest close, BioVie traded at $1.19 with a market cap of $22.10 million and volume of 384,207 shares. Receive BIVI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+10.19%1 Month Performance+11.21%3 Month Performance+16.67%Year-To-Date Performance-40.50%1 Year Performance+144.76% BIVI Stock Chart for Friday, June, 13, 2025 BIVI Chart by TradingView BioVie Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/12/2025$1.11$1.19+7.21%$1.21$1.11384,207 shs$22.10 million06/11/2025$1.10$1.11+0.91%$1.13$1.08148,912 shs$20.61 million06/10/2025$1.12$1.10-1.79%$1.18$1.08205,450 shs$20.43 million06/09/2025$1.08$1.12+3.70%$1.12$1.07164,833 shs$20.80 million06/06/2025$1.09$1.08-0.92%$1.12$1.08194,103 shs$20.05 million06/05/2025$1.09$1.09$1.12$1.06143,011 shs$20.23 million06/04/2025$1.11$1.09-1.80%$1.13$1.08120,825 shs$20.23 million06/03/2025$1.07$1.11+3.74%$1.12$1.04241,564 shs$20.60 million06/02/2025$1.02$1.07+5.42%$1.09$1.01207,742 shs$19.86 million05/30/2025$1.06$1.02-4.25%$1.07$0.99260,201 shs$18.84 million Get the Latest News and Ratings for BIVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025$1.04$1.06+1.92%$1.09$1.04326,036 shs$19.68 million05/28/2025$1.05$1.04-0.95%$1.05$1.02126,504 shs$19.30 million05/27/2025$1.03$1.05+1.94%$1.07$1.02203,562 shs$19.49 million05/26/2025$1.03$1.03$1.05$1.0288,634 shs$19.12 million05/23/2025$1.03$1.03$1.05$1.0288,634 shs$19.12 million05/22/2025$1.00$1.03+3.00%$1.05$1.00203,266 shs$19.12 million05/21/2025$1.04$1.00-3.85%$1.06$1.00220,781 shs$18.56 million05/20/2025$1.07$1.04-2.80%$1.06$1.03191,046 shs$19.30 million05/19/2025$1.03$1.07+3.88%$1.08$0.98235,884 shs$19.86 million05/16/2025$1.05$1.03-1.90%$1.10$1.02509,043 shs$19.01 million05/15/2025$1.10$1.05-4.55%$1.10$1.00372,942 shs$19.38 million05/14/2025$1.07$1.10+2.80%$1.13$1.05446,714 shs$20.30 million05/13/2025$1.15$1.07-6.96%$1.14$1.05472,728 shs$19.74 million05/12/2025$1.12$1.15+3.14%$1.20$1.11548,231 shs$21.22 million Related Companies Sutro Biopharma Stock Chart ESSA Pharma Stock Chart Pyxis Oncology Stock Chart Adaptimmune Therapeutics Stock Chart IGM Biosciences Stock Chart Tenaya Therapeutics Stock Chart Immix Biopharma Stock Chart InterCure Stock Chart Elutia Stock Chart PyroGenesis Canada Stock Chart Receive BIVI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BIVI) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
